"Oncogene Proteins v-abl" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transforming proteins encoded by the abl oncogenes. Oncogenic transformation of c-abl to v-abl occurs by insertional activation that results in deletions of specific N-terminal amino acids.
| Descriptor ID |
D016374
|
| MeSH Number(s) |
D12.776.624.664.520.750.875 D12.776.964.700.750.875 D12.776.964.775.750.875
|
| Concept/Terms |
Oncogene Proteins v-abl- Oncogene Proteins v-abl
- Oncogene Proteins v abl
- Proteins v-abl, Oncogene
- v-abl, Oncogene Proteins
- v-abl Proteins
- v abl Proteins
- abl Oncogene Proteins
- Oncogene Proteins, abl
- Oncogene Products v-abl
- Oncogene Products v abl
- Products v-abl, Oncogene
- v-abl, Oncogene Products
|
Below are MeSH descriptors whose meaning is more general than "Oncogene Proteins v-abl".
Below are MeSH descriptors whose meaning is more specific than "Oncogene Proteins v-abl".
This graph shows the total number of publications written about "Oncogene Proteins v-abl" by people in this website by year, and whether "Oncogene Proteins v-abl" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Oncogene Proteins v-abl" by people in Profiles.
-
Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia? Leuk Lymphoma. 2011 Jun; 52(6):1010-6.
-
Does a rise in the BCR-ABL1 transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse? Br J Haematol. 2009 May; 145(3):373-5.
-
FBP WW domains and the Abl SH3 domain bind to a specific class of proline-rich ligands. EMBO J. 1997 May 01; 16(9):2376-83.